Ordinary Index Re-Weighting in the Solactive Europe & US Top Pharmaceuticals 2020 AR 3.5% Index | January 2022

In the ordinary re-weighting the following composition will be implemented effective open 05.01.2022:

ABBVIE INC
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB CO
JOHNSON & JOHNSON
MERCK & CO. INC.
NOVARTIS AG
NOVO NORDISK A/S
PFIZER INC
ROCHE HOLDING AG
SANOFI SA